No abstract available
MeSH terms
-
Angiogenesis Inhibitors / administration & dosage
-
Antineoplastic Agents / administration & dosage
-
Carcinoma, Non-Small-Cell Lung / genetics*
-
Carcinoma, Non-Small-Cell Lung / mortality
-
Clinical Trials as Topic
-
Disease-Free Survival
-
ErbB Receptors / genetics*
-
Erlotinib Hydrochloride / administration & dosage
-
Exons
-
Female
-
Gefitinib
-
Gene Deletion
-
Humans
-
Lung Neoplasms / genetics*
-
Lung Neoplasms / mortality
-
Middle Aged
-
Mutation*
-
Neoplasm Metastasis
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Quinazolines / administration & dosage
-
Treatment Outcome
Substances
-
Angiogenesis Inhibitors
-
Antineoplastic Agents
-
Quinazolines
-
Erlotinib Hydrochloride
-
EGFR protein, human
-
ErbB Receptors
-
Protein-Tyrosine Kinases
-
Gefitinib